Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine: Ongoing collaboration with Dr. Atala regarding commercialization opportunities for PAC5.
Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine: Ongoing collaboration with Dr. Atala regarding commercialization opportunities for PAC5.
S. Army ATACCC, Ft. Detrick MD, Col. Robert Vandre, Area Director for Combat Casualty Care Research: “Combat Wound Disinfection and Healing / Investigation of a Topical Antiseptic (Grant Log 04054001).”
“Cytotoxic Effect of an Anti-Microbial Compound on Cultured Murine Cells” (December 2001) by Jamuna Ramnath, PhD, Cell Biologist/Molecular Biologist, and Joseph R. Landolph, PhD, Molecular Biologist/Genetic Toxicologist
The Killing and Solubilizing Effects of Solution A on Homogenous and Heterogeneous Planktonic Organisms, Biofilm Organisms, and Biofilm Structures” – Beierle Lab Technologies, John W. Beierle, PhD, Consultant
“The Efficacy of Compound A in Killing Planktonic and Biofilm Cells Using Modern Methods Suitable for FDA Submissions” (May 2001) by J. William Costerton, PhD, Consultant
Montana State University Center for Biofilm Engineering, Dr. William Costerton, Director: Conference presentation – “Biofilm Revolution.”